Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Real-World Study EvalUating the EffectiveNess and Safety of RISankizumab in PatiEnts With Ulcerative Colitis (SUNRISE-UC)

NCT06764706 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06764706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06764706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Real-World Study EvalUating the EffectiveNess and Safety of RISankizumab in PatiEnts With Ulcerative Colitis (SUNRISE-UC)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2025
Completion date
July 31, 2028
Enrollment
200 (estimated)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis